The septin 9 (SEPT9) gene promoter region was initially identified as being differentially methylated in a discovery project comparing colorectal tumors, healthy adjacent tissues, peripheral blood lymphocytes, and other non-colonic, non-pathologic control tissues which could hypothetically contribute DNA to plasma (Lofton-Day et al., 2008). Here, SEPTIN9 is linked to colorectal neoplasm.